Skip to main content
. 2020 Apr 1;27(4):375–396. doi: 10.5551/jat.50948

Table 3. Investigation of the efficacy of Pitavastatin and Atorvastatin on 207 dyslipidemia patients with impaired glucose tolerance (ref 24).

Week 8 Week 28 Week 56
Pitavastatin 98% (86/88) 94% (83/88) 93% (79/85)
Atorvastatin 100% (84/84) 96% (81/84) 98% (80/82)